# DROSPIRENONE AND ETHINYL ESTRADIOL
> **ANDA203291** · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2017-07-18
## Drug
- **FDA Application Number:** ANDA203291
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DROSPIRENONE AND ETHINYL ESTRADIOL
- **Generic name:** Drospirenone
- **Active ingredients:** DROSPIRENONE; ETHINYL ESTRADIOL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PHARMOBEDIENT
- **First approval:** 2017-07-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203291)
---
*MORVS · CC0 1.0*